• Research Activities

April 8, 2024

  • Press Releases

Itabashi CampusA research group led by Professor Suzuki of the Faculty of Pharma-Science has developed a new polymer-bound anticancer drug.

On Monday, April 8, 2024, Professor Ryo Suzuki of the Department Faculty of Pharma-Science Delivery Science, Faculty of Pharmaceutical Sciences, Teikyo University, in a non-clinical study conducted in collaboration with Toray Industries, Inc. and Professor Yasuhito Uezono of the Department of Pain Control Research, Jikei University School of Medicine, confirmed that a polymer-bound anticancer drug (code name: TXB-001) exhibits strong anticancer effects against multiple types of solid cancers and significantly reduces multiple toxicities, including cardiotoxicity, observed in existing anthracycline anticancer drugs.

To the topic List